Ligand Pharma (LGND) PT Raised to $162 at Stephens Citing Compelling Risk/Reward on Co's Imaging Agent Work
Tweet Send to a Friend
Stephens raised its price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
